BIOENGINEER

ClinGen framework reveals recurrent CNV burden in diagnostic microarray series

A ClinGen-anchored review of 2,062 constitutional microarray cases found that recurrent CNVs formed about one-quarter of pathogenic findings, but prenatal events were less likely to be pathogenic than ...
BIOENGINEER

Eight-Gene Blood Test Shows Striking Accuracy in Detecting Heart Attacks

Researchers used nested machine learning on public blood transcriptome data to derive an eight-gene index that diagnoses ...

Microarray Market - Global Industry Analysis and Forecast, 2026-2032 | AI-Enabled Analytics and Precision Medicine Drive 9.10% CAGR Toward USD 11.79 Billion by 2032

Dublin, Oct. 19, 2026 (GLOBE NEWSWIRE) -- "Microarray Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. This market research report examines the global ...

Genetic Screening and Testing for Reproductive Health Market, 2026-2036 | NIPT, IVF, PGT, and NGS Adoption to Drive 9.73% CAGR and $24.7 Billion Opportunity

Recurring services and consumables, centralized high-throughput labs, automation, payer connectivity and outsourced testing support scale, efficiency and sustainable returns.Dublin, Oct. 16, 2026 ...